| scholarly article | Q13442814 |
| P2093 | author name string | Michael A Marletta | |
| Jonathan A Winger | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4083-4090 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Expression and characterization of the catalytic domains of soluble guanylate cyclase: interaction with the heme domain | |
| P478 | volume | 44 |
| Q27319501 | A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer |
| Q83227485 | Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy |
| Q35855521 | Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation |
| Q45928927 | Biochemical and structural characterization of C-terminal constructs of bovine soluble guanylate cyclase. |
| Q45953522 | Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase. Investigating the role of non-heme nitric oxide. |
| Q37395595 | Characterization of two different five-coordinate soluble guanylate cyclase ferrous-nitrosyl complexes |
| Q36065378 | Computational exploration of the binding mode of heme-dependent stimulators into the active catalytic domain of soluble guanylate cyclase. |
| Q27659219 | Crystal structure of the signaling helix coiled-coil domain of the β1 subunit of the soluble guanylyl cyclase |
| Q24336722 | Crystal structures of the catalytic domain of human soluble guanylate cyclase |
| Q45060738 | Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling |
| Q46525246 | Direct evidence for close proximity of catalytic and regulatory domains of heterodimeric sGC based on fluorescence resonance energy transfer |
| Q43862233 | Dynamic change of heme environment in soluble guanylate cyclase and complexation of NO-independent drug agents with H-NOX domain |
| Q92420811 | Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? |
| Q27021649 | Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS |
| Q33640041 | Fluorescent fusion proteins of soluble guanylyl cyclase indicate proximity of the heme nitric oxide domain and catalytic domain |
| Q89660045 | Guanylyl Cyclase-cGMP Signaling Pathway in Melanocytes: Differential Effects of Altered Gravity in Non-Metastatic and Metastatic Cells |
| Q42511668 | Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1. |
| Q38094133 | Heme sensor proteins |
| Q30539237 | Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase. |
| Q28477878 | Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity |
| Q42380504 | Inhibition of soluble guanylyl cyclase by small molecules targeting the catalytic domain |
| Q27677544 | Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes |
| Q27680135 | Insights into Soluble Guanylyl Cyclase Activation Derived from Improved Heme-Mimetics |
| Q27682500 | Interfacial residues promote an optimal alignment of the catalytic center in human soluble guanylate cyclase: heterodimerization is required but not sufficient for activity |
| Q41823943 | Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways |
| Q35855381 | Mapping Soluble Guanylyl Cyclase and Protein Disulfide Isomerase Regions of Interaction |
| Q91827695 | Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain |
| Q36713981 | Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking |
| Q27641107 | NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism |
| Q24656131 | NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential |
| Q41848414 | Nitric oxide activation of guanylate cyclase pushes the α1 signaling helix and the β1 heme-binding domain closer to the substrate-binding site. |
| Q37727207 | Nitric oxide-induced conformational changes in soluble guanylate cyclase |
| Q37342409 | Nucleotide regulation of soluble guanylate cyclase substrate specificity |
| Q27649070 | PAS-mediated Dimerization of Soluble Guanylyl Cyclase Revealed by Signal Transduction Histidine Kinase Domain Crystal Structure |
| Q88500342 | Physiological activation and deactivation of soluble guanylate cyclase |
| Q36641270 | Primary response of the sGC heme binding domain to the cleavage of the Fe-His bond |
| Q37660997 | Probing the Molecular Mechanism of Human Soluble Guanylate Cyclase Activation by NO in vitro and in vivo |
| Q96302505 | Probing the Structural Dynamics of the Catalytic Domain of Human Soluble Guanylate Cyclase |
| Q37712434 | Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity |
| Q38569329 | Recent trends in the development of vitamin B12 derivatives for medicinal applications |
| Q36480286 | Regulation of Neuronal Oxygen Responses in C. elegans Is Mediated through Interactions between Globin 5 and the H-NOX Domains of Soluble Guanylate Cyclases. |
| Q37697630 | Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow. |
| Q37612777 | Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase |
| Q46442525 | Soluble guanylate cyclase crystal clear: 1st crystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q47423710 | Structure and monomer/dimer equilibrium for the guanylyl cyclase domain of the optogenetics protein RhoGC. |
| Q27661554 | Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase |
| Q34990290 | Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase |
| Q55436230 | Structure/function of the soluble guanylyl cyclase catalytic domain. |
| Q38180766 | Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development |
| Q41998443 | The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE. |
| Q28744371 | The amino-terminus of nitric oxide sensitive guanylyl cyclase α₁ does not affect dimerization but influences subcellular localization |
| Q38130465 | The chemistry and biology of soluble guanylate cyclase stimulators and activators |
| Q27652454 | The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase |
| Q33948069 | Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP |
| Q37557818 | YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit. |
Search more.